Decoding Cancer - Lung Cancer: Can Early Detection Save Lives?
The Irish Cancer Society Research Department are pleased to announce that the January Decoding Cancer talk entitled Decoding Cancer - Lung Cancer: Can Early Detection Save Lives?
will take place 6.30pm, Tuesday, 24 January 2017 in the Trinity Biomedical Sciences Institute, 152 - 160 Pearse Street, Dublin 2 (Next to Pearse DART station).
Over 2,200 cases of lung cancer are diagnosed in Ireland each year. Because the disease is often detected in advanced stages, for every 20 patient diagnosed only 3 three will be alive 5 years later. Not smoking would prevent almost all cases of lung cancer, but nicotine remains a significant addiction. Prof. John field is an internationally recognised expert in lung cancer treatment who is making major contributions to our understanding of ways to improve survival through UK and European research. He will present findings on the latest research on lung screening which suggest novel approaches to reduce lung disease and cancer death.
- Professor John Field -
Professor John Field, PhD, FRCPath has a Personal Clinical Chair in Molecular Oncology at the University of Liverpool. He is a Visiting Professor at University College London, holds the post of Director of Research of the Roy Castle Lung Cancer Research Programme. He is the CI for the UK Lung Cancer Screening Trial (UKLS), Chair of the EU-US Spiral CT collaborative group, Chair (2011- ) IASLC Early Detection and Prevention Committee. Presented with the IASLC Joseph Cullen Award at the WCLC 2011, in recognition of lifetime scientific achievements in lung cancer prevention research.
He is the principle investigator of the Liverpool Lung Project, a 10 year molecular- epidemiological study into the early detection of lung cancer, funded by the Roy Castel Lung Cancer Foundation. He is also PI on the large EU Early Lung Cancer study funded by the Commission. Both of these trials form part of the NCRI Lung Cancer clinical studies group’s portfolio. He is a member of the NCRI Lung Cancer Clinical Study Group and Chairs the Lung Cancer Translational Sub-group. He is also heavily involved in the identification of molecular diagnostic markers in lung and head & neck cancer and has led the team searching for the familial oesophageal cancer gene (TOC) over the past decade, His research funding has been provided mainly by the RCF, NWCRF, MRC, CRC, EU and HTA .
Professor Field is the author of over 200 international (peer reviewed) papers in his area of expertise and has given more than 270 presentations at medical and scientific conferences around the world.
This event is FREE but registration is required.
For more information please contact email@example.com.